title: India's growing participation in global clinical trials.
abstract: Lower operational costs, recent regulatory reforms and several logistic advantages make India an attractive destination for conducting clinical trials. Efforts for maintaining stringent ethical standards and the launch of Pharmacovigilance Program of India are expected to maximize the potential of the country for clinical research.
authors.affiliation: Department of Pharmacology, All India Institute of Medical Sciences, New Delhi 110029, India.
authors.forename: Yogendra K
authors.initials: YK
authors.lastname: Gupta
authors.forename: Biswa M
authors.initials: BM
authors.lastname: Padhy
mesh_terms: D035843:Biomedical Research / Q000191:economics / Q000941:ethics / Q000639:trends; D002986:Clinical Trials as Topic / Q000191:economics* / Q000941:ethics* / Q000639:trends; D003132:Commerce / Q000191:economics / Q000639:trends; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration / Q000639:trends; D006801:Humans; D007194:India; D007258:Informed Consent / Q000941:ethics / Q000331:legislation & jurisprudence; D007391:International Cooperation; D020416:Outsourced Services / Q000191:economics* / Q000941:ethics / Q000639:trends